{{Rsnum
|rsid=12262754
|Gene=GRID1
|Chromosome=10
|position=87929082
|Orientation=plus
|GMAF=0.1873
|Assembly=GRCh37
|GenomeBuild=37.1
|dbSNPBuild=131
|geno1=(A;A)
|geno2=(A;G)
|geno3=(G;G)
}}
{{ population diversity
| geno1=(A;A)
| geno2=(A;G)
| geno3=(G;G)
| CEU | 1.8 | 19.5 | 78.8
| HCB | 0.7 | 22.1 | 77.2
| JPT | 2.7 | 20.4 | 77.0
| YRI | 14.3 | 52.4 | 33.3
| ASW | 7.0 | 45.6 | 47.4
| CHB | 0.7 | 22.1 | 77.2
| CHD | 0.0 | 21.1 | 78.9
| GIH | 11.9 | 44.6 | 43.6
| LWK | 13.6 | 49.1 | 37.3
| MEX | 1.7 | 27.6 | 70.7
| MKK | 5.8 | 39.1 | 55.1
| TSI | 3.9 | 21.6 | 74.5
| HapMapRevision=28
}}{{PharmGKB
|RSID=rs12262754
|Name_s=
|Gene_s=GRID1
|Feature=
|Evidence=PubMed ID:17537913
|Annotation=Risk or phenotype-associated allele: not stated Phenotype: Using a Quantitative Transmission Disequilibrium Test (QTDT), this variant was significantly associated with etoposide toxicity based upon IC50 values in cell lines from 30 parent-child trios. Study size: 87. Study population/ethnicity: 87 European descent Caucasians. Significance metric(s): p = 0.00002. Type of association: FA; GN.
|Drugs=etoposide
|Drug Classes=
|Diseases=Drug Toxicity
|Curation Level=Curated
|PharmGKB Accession ID=PA165109409
}}

{{GET Evidence
|impact=pharmacogenetic
|qualified_impact=Insufficiently evaluated pharmacogenetic
|inheritance=unknown
|quality_scores=Array
|dbsnp_id=rs12262754
|overall_frequency_n=26
|overall_frequency_d=128
|overall_frequency=0.203125
|n_genomes=23
|n_genomes_annotated=0
|n_haplomes=26
|n_articles=1
|n_articles_annotated=0
|in_pharmgkb=Y
|autoscore=1
|webscore=N
}}

{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | Affy GenomeWide 6}}
{{on chip | FTDNA2}}
{{on chip | FTDNA}}
{{on chip | HumanOmni1Quad}}
{{on chip | Illumina Human 1M}}